Major Funds Exit UnitedHealth as Stock Plunge Deepens

UnitedHealth Group is facing a significant withdrawal of institutional support despite the healthcare giant’s efforts to bolster investor confidence through raised profit forecasts and strategic restructuring plans. The stock has collapsed more than 36% since the start of the year, prompting prominent hedge funds including Soros Fund Management and Lone Pine Capital to substantially reduce or completely liquidate their holdings. This exodus of major investors raises critical questions about the company’s near-term prospects.

Market analysts present a conflicting picture. The average analyst rating continues to favor buying the shares, with a consensus price target of $395.67, suggesting substantial potential upside from current levels. RBC Capital Markets notably increased Read more...